| 000 | 01309 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250517014609.0 | ||
| 264 | 0 | _c20160516 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1744-7674 | ||
| 024 | 7 |
_a10.1517/13543776.2015.1012155 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDesogus, Andrea | |
| 245 | 0 | 0 |
_aBcr-Abl tyrosine kinase inhibitors: a patent review. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic patents _cApr 2015 |
||
| 300 |
_a397-412 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aPatents as Topic |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 700 | 1 | _aSchenone, Silvia | |
| 700 | 1 | _aBrullo, Chiara | |
| 700 | 1 | _aTintori, Cristina | |
| 700 | 1 | _aMusumeci, Francesca | |
| 773 | 0 |
_tExpert opinion on therapeutic patents _gvol. 25 _gno. 4 _gp. 397-412 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543776.2015.1012155 _zAvailable from publisher's website |
| 999 |
_c24599264 _d24599264 |
||